ghk-cu diabetic ulcer clinical trial Dimeric copper peptide incorporated hydrogel for promoting wound healing GHK-Cu – 50mg – Prime

(2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa

Explore nutrient-peptide synergies for comprehensive protocols

MMP inhibition: GHK-Cu suppresses MMP-1 (interstitial collagenase) and MMP-9 (gelatinase B) expression in cultured fibroblasts, reducing collagen degradation alongside synthesis promotion

But they come with significant drawbacks: high cost, injection site reactions, increased infection risk due to immune suppression, and the development of anti-drug antibodies over time that can reduce efficacy

Maximum results are typically observed at 4-6 months of consistent use